Neumora Therapeutics Inc (NAS:NMRA)
$ 1.255 -0.060 (-4.58%) Market Cap: 235.81 Mil Enterprise Value: 171.29 Mil PE Ratio: 0 PB Ratio: 5.21 GF Score: 11/100

Q2 2025 Neumora Therapeutics Inc Earnings Call Transcript

Aug 6, 2025 / 08:30 PM GMT
Release Date Price: $1.59 (-4.22%)


Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

NMRA.OQ - Neumora Therapeutics Inc
Q2 2025 Neumora Therapeutics Inc Earnings Call
Aug 06, 2025 / 08:30PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Ladies and gentlemen, thank you for standing by. This is RG, your conference operator today. At this time, all participants are in a listen-only mode. After the speaker's presentation, there will be a question and answer session. Please be advised that today's conference is being recorded. I would like now to turn the conference over to Helen Robbinstein, Vice President of investor relations and communications. Please go ahead.

--------------------------------------------------------------------------------
Unidentified_2 [2]
--------------------------------------------------------------------------------
Good afternoon and thank you for joining Numura Therapeutic 2nd quarter 2025 Financial results
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot